# Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy

> **NCT02786810** · PHASE2 · COMPLETED · sponsor: **University of Tennessee** · enrollment: 10 (actual)

## Conditions studied

- Urinary Tract Infection
- Vesicoureteral Reflux

## Interventions

- **DRUG:** Sulfur hexafluoride type-a lipid microspheres

## Key facts

- **NCT ID:** NCT02786810
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02786810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02786810, "Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02786810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*